Joon Bok Lee

This inventor holds 47 USPTO granted patents and 99 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Automated Insulin Delivery. Top assignee: Insulet Corporation. Active years: 2022-2026.

USPTO Granted Patents = 47 (Patent Applications = 99)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 24)

EPO Patents = 11 (Patent Applications = 90)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 41(Granted Patents)

Location History:

Lowell, MA (US) (2023)
Acton, MA (US) (2022 - 2024)

Company Filing History:

47 out of 234

Insulet Corporation

patents

Years Active: 2022-2026

Loading Chart...

Areas of Expertise:

Insulin Delivery

Hypoglycemia Reduction

Drug Delivery Optimization

Artificial Pancreas

Glucose Control

Patient Personalization

Co-Formulations

Meal Detection

Dosage Adjustment

Closed Loop System

Fuzzy Logic

Occlusion Prevention

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12728203 - Techniques for recommending rescue carbohydrate ingestion in automatic medication delivery systems (2026-09-08),

2. 12714785 - Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns (2026-08-25),

3. 12708709 - ADAPTATION OF AUTOMATIC INSULIN DELIVERY (AID) FOR USERS WITH BASAL TO BOLUS MISMATCH (2026-08-18),

4. 12691222 - Techniques for determining medication correction factors in automatic medication delivery systems (2026-07-28),

5. 12667665 - Techniques and devices that adapt basal profiles for drug delivery applications (2026-06-30),

6. 12592306 - Devices and methods for initialization of drug delivery devices using measured analyte sensor information (2026-03-31),

7. 12569619 - Techniques for determining automated insulin delivery dosages (2026-03-10),

8. 12564679 - Adjusting medicament delivery parameters in an open loop medicament delivery mode (2026-03-03),

9. 12551619 - Automated insulin delivery system using pramlintide (2026-02-17),

10. 12544510 - Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system (2026-02-10),

11. 12496399 - Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk (2025-12-16),

12. 12496398 - Threshold based automatic glucose control response (2025-12-16),

13. 12495994 - Meal bolus subcategories in model based insulin therapy (2025-12-16),

14. 12491316 - Scheduling of medicament bolus deliveries by a medicament delivery device at future dates and times with a computing device (2025-12-09),

15. 12433998 - Activity mode for artificial pancreas system (2025-10-07),

Title: Joon Bok Lee - Shaping the Future of Diabetes Treatment through Innovation

Introduction:

Joon Bok Lee, a passionate inventor based in Acton, MA, is making waves in the field of healthcare technology with his groundbreaking innovations and relentless pursuit of excellence. With a total of 17 patents to his name, Lee's work is revolutionizing the way diabetes treatment is personalized and delivered.

Latest Patents:

Lee's latest patents focus on providing adaptivity and personalization in diabetes treatment. His inventions include techniques and devices that update insulin-to-carbohydrate ratios and total daily insulin doses, enabling more precise and tailored treatment for individuals with diabetes.

Career Highlights:

Currently working at Insulet Corporation, Lee has established himself as a key player in the development of innovative medical devices. His commitment to enhancing the quality of life for patients with diabetes is evident in his portfolio of patents and contributions to the healthcare industry.

Collaborations:

Among Lee's esteemed coworkers are Yibin Zheng and Jason B. O'Connor. Together, they form a dynamic team at Insulet Corporation, driving forward advancements in technology that have a direct impact on patient care and well-being.

Conclusion:

Joon Bok Lee's dedication to innovation and his significant contributions to the field of healthcare technology serve as inspiration for the next generation of inventors. By combining his expertise with a steadfast commitment to excellence, Lee is shaping the future of diabetes treatment and paving the way for a healthier, more personalized approach to medical care.